Mark Basik

9PUBLICATIONS
130CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyPredictive and prognostic markersDeep learningCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 13, 2026
ATR and PKMYT1 Inhibition Resensitizes a Subset of TNBC Patient-Derived Models to Carboplatin, Inducing Mitotic Catastrophe.

Juliet Guay, Hellen Kuasne, Catherine Chabot

|Mar 10, 2026
Treatment Patterns and Clinical Outcomes in Metastatic HR+/HER2- and Triple-Negative Breast Cancer in Canada: The HER2- TRENDS Study.

Karen Gambaro, Kahina Rachedi, Mark Basik

|Feb 09, 2026
Clinical Validation of Digital PCR-Based ctDNA Detection for Risk Stratification in Residual Triple-Negative Breast Cancer: TRICIA Trial Results.

Talia Roseshter, Anna Klemantovich, Josiane Lafleur

|Jun 09, 2025
Federated Deep Learning Enables Cancer Subtyping by Proteomics.

Zhaoxiang Cai, Emma L Boys, Zainab Noor

|Jan 24, 2025
The Real-World Clinical Outcomes of Heavily Pretreated HER2+ and HER2-Low Metastatic Breast Cancer Patients Treated with Trastuzumab Deruxtecan at a Single Centre.

Anna-Maria Lazaratos, Matthew Dankner, Aalya Hamouda

|Dec 26, 2024
Clinical Proteomics Reveals Vulnerabilities in Noninvasive Breast Ductal Carcinoma and Drives Personalized Treatment Strategies.

Georgia Mitsa, Livia Florianova, Josiane Lafleur

Pageof 2

Frequent Collaborators

4 joint publications

Adriana Aguilar-Mahecha

2 joint publications

Kathryn Bozek

2 joint publications

Juliet Guay

2 joint publications

Gerald Batist